| Particulars (Rupees in Crores.) | Sept-2024 | Mar-2024 | Sept-2023 | Mar-2023 | Sept-2022 |
|---|---|---|---|---|---|
Gross Sales | 429.55 | 344.76 | 325.79 | 281.34 | 238.96 |
Excise Duty | 0 | 0 | 0 | 0 | 0 |
Net Sales | 429.55 | 344.76 | 325.79 | 281.34 | 238.96 |
Other Operating Income | 0 | 0 | 0 | 0 | 0 |
Other Income | 6.62 | 11.03 | 4.58 | 1.48 | 1.33 |
Total Income | 436.18 | 355.79 | 330.37 | 282.81 | 240.29 |
Total Expenditure | 321.25 | 251.8 | 238.8 | 206.78 | 179.75 |
PBIDT | 114.92 | 103.99 | 91.56 | 76.04 | 60.54 |
Interest | 4.48 | 0.55 | 8.87 | 11.91 | 9.48 |
PBDT | 110.44 | 103.44 | 82.69 | 64.13 | 51.06 |
Depreciation | 27.39 | 15.55 | 13.75 | 15.16 | 12.35 |
Minority Interest Before NP | 0 | 0 | 0 | 0 | 0 |
Tax | 24.18 | 18.33 | 22.44 | 12.79 | 13.14 |
Deferred Tax | -2.47 | 1.73 | -0.14 | -2.4 | -1.62 |
Reported Profit After Tax | 61.34 | 67.84 | 46.64 | 38.57 | 27.2 |
Minority Interest After NP | 0 | 0 | 0 | 0 | 0 |
Net Profit after Minority Interest | 61.34 | 67.84 | 46.64 | 38.57 | 27.2 |
Extra-ordinary Items | 0 | 0 | 0 | 0 | 0 |
Adjusted Profit After Extra-ordinary item | 61.34 | 67.84 | 46.64 | 38.57 | 27.2 |
EPS (Unit Curr.) | 7.13 | 7.9 | 6.42 | 5.89 | 4.15 |
Book Value (Unit Curr.) | 0 | 0 | 0 | 0 | 0 |
Dividend (%) | 0 | 0 | 0 | 0 | 0 |
Equity | 85.85 | 85.85 | 85.85 | 65.52 | 65.52 |
Public Shareholding (Number) | 0 | 0 | 0 | 0 | 0 |
Public Shareholding (%) | 0 | 0 | 0 | 0 | 0 |
Pledged/Encumbered - No. of Shares | 0 | 0 | 0 | 0 | 0 |
Pledged/Encumbered - % in Total Promoters Holding | 0 | 0 | 0 | 0 | 0 |
Pledged/Encumbered - % in Total Equity | 0 | 0 | 0 | 0 | 0 |
Non Encumbered - No. of Shares | 0 | 0 | 0 | 0 | 0 |
Non Encumbered - % in Total Promoters Holding | 0 | 0 | 0 | 0 | 0 |
Non Encumbered - % in Total Equity | 0 | 0 | 0 | 0 | 0 |
PBIDTM(%) | 26.75 | 30.16 | 28.1 | 27.02 | 25.33 |
PBDTM(%) | - | - | - | - | - |
PATM(%) | 14.28 | 19.67 | 14.31 | 13.7 | 11.38 |
The QIP shares were at ₹595 per share which was 5% lower compared with the floor price of ₹626.
The strategic purchase intends to increase Yatharth Hospital's presence in the Delhi-NCR region, hence increasing its regional footprint.
This strategic acquisition is intended to strengthen Yatharth Hospital's presence in the Delhi-NCR region and expand its reach to serve a larger population.
Invest wise with Expert advice
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
